{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04167163","recordId":"NCT04167163","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04167163-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04167163.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04167163.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-11-15","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"fc2c7a4538600fffac65e7d5b2642eb864bea70abbaac6c3c8bd9e7a8aa0486c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2019-12-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2019-12-02","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"9ffcab5a8b1bb785adf4f82baf9e12f819ac9eca1996d1149488e73f54ffe9dc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-01-06","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"b59f321b9b9ba7070db4eb4abb4ada8973c6f5fd30097af391684ea156e19868","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-01-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-01-08","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"7f172d9d72ff16aef2fbc6733386c5e46659493d362ffc37105c7ec4bb530ad8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2020-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-01-10","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"e72eb58c9d6a962c18e281c94df34c27b952ad7cc084b0bc4b796fddbc4fde5a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-02-04","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"b378c4cf9493ad5990bf1793ddc234bb68a655e13aa3cfe73f84e2ff4b02556f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2021-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-02-04","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"be224ed8f47257b59864c6716d78415fb287bc9323295c16533fd910fcdc2d2a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2021-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-05-03","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"acef22e606cfdf119f40b1fa1a0d7e6ab6d0e54f4d98f4485d9c27dc99464ffa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2022-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2022-04-07","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"f01178024ae8139ebdd997bb2ac60782b7a03e37f5673ee0aa7cbe3c10e68083","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2023-03-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2023-03-13","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"6983f2debc9bca7f280c34e662acc3cca69b5dc157ef585dd6bca0fba09f06ae","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2023-11-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2023-11-20","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"c5c1b515e3347df8241e53ec9dc7cf31004e8e00be10df65f6e65ca32838976d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2024-06-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2024-06-07","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"6d489a80312ac75b5a19a4c3a3408b206765557bd0c6c447aa4b8962e03be54d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2025-01-28","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"0a9b21fb640e16197b35a4bb3bc5d9e53a73eb43328b484ac890a245db4f2f03","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2025-04-03","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"ce0071f825926529f4eed954db6bd3ceeb8891b673437f0328c458a9977d041a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2026-05-11","publishedAt":"2026-08-23","recordId":"NCT04167163","recordSha256":"c49c17bdd007d5c950262d907bdccd0e48da2e9cee0cca5b3ac6fb974ef250c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04167163?a=16&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1b2464bf7b091d37fde8f6a6c9e08b1c4ddeb8643c54e65598904adc715ab68d"}}